Magle Chemoswed Feed

	Est. tid*
2027-02-24	08:30	Bokslutskommuniké 2026
2026-11-02	08:30	Kvartalsrapport 2026-Q3
2026-08-05	08:30	Kvartalsrapport 2026-Q2
2026-05-27	N/A	X-dag ordinarie utdelning MAGLE 0.00 SEK
2026-05-26	N/A	Årsstämma
2026-05-18	08:30	Kvartalsrapport 2026-Q1
2026-04-10	-	Extra Bolagsstämma 2026
2026-03-27	-	Bokslutskommuniké 2025
2025-11-14	-	Kvartalsrapport 2025-Q3
2025-08-01	-	Kvartalsrapport 2025-Q2
2025-05-27	-	X-dag ordinarie utdelning MAGLE 0.00 SEK
2025-05-26	-	Årsstämma
2025-05-22	-	Kvartalsrapport 2025-Q1
2025-03-27	-	Bokslutskommuniké 2024
2024-12-30	-	Extra Bolagsstämma 2025
2024-10-24	-	Kvartalsrapport 2024-Q3
2024-10-04	-	Extra Bolagsstämma 2024
2024-07-18	-	Kvartalsrapport 2024-Q2
2024-04-26	-	X-dag ordinarie utdelning MAGLE 0.00 SEK
2024-04-25	-	Årsstämma
2024-04-18	-	Kvartalsrapport 2024-Q1
2024-02-16	-	Bokslutskommuniké 2023
2023-10-25	-	Kvartalsrapport 2023-Q3
2023-07-18	-	Kvartalsrapport 2023-Q2
2023-04-27	-	X-dag ordinarie utdelning MAGLE 0.00 SEK
2023-04-26	-	Årsstämma
2023-02-16	-	Bokslutskommuniké 2022
2022-11-09	-	Kvartalsrapport 2022-Q3
2022-08-17	-	Kvartalsrapport 2022-Q2
2022-05-19	-	X-dag ordinarie utdelning MAGLE 0.00 SEK
2022-05-17	-	Årsstämma
2022-05-05	-	Kvartalsrapport 2022-Q1
2022-02-25	-	Bokslutskommuniké 2021
2021-12-14	-	Extra Bolagsstämma 2021
2021-11-16	-	Kvartalsrapport 2021-Q3
2021-08-17	-	Kvartalsrapport 2021-Q2
2021-05-14	-	Kvartalsrapport 2021-Q1
2021-05-03	-	X-dag ordinarie utdelning MAGLE 0.00 SEK
2021-04-18	-	Årsstämma
2021-02-25	-	Bokslutskommuniké 2020
2020-11-27	-	Extra Bolagsstämma 2020
2020-11-05	-	Kvartalsrapport 2020-Q3
2020-07-14	-	Kvartalsrapport 2020-Q2

Land	Sverige
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Medicinteknik

2026-04-10 11:27:00 Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) 4,46 SEK | +16,15%

2026-04-10 11:27:00 Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ) 4,46 SEK | +16,15%

2026-03-27 08:30:00 Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2025 3,96 SEK | -7,04% | 0,18 MSEK

2026-03-26 16:35:00 Magle Chemoswed Holding AB (publ) initiates written procedure to amend the terms and conditions of its senior secured bonds 2025/2028 0,54 MSEK

2026-03-25 21:26:00 Notice to the extraordinary general meeting in Magle Chemoswed Holding AB (publ) 4,26 SEK | -43,20% | 0,54 MSEK

2026-03-25 21:26:00 Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ) 4,26 SEK | -43,20% | 0,54 MSEK

2026-03-25 20:46:00 MAGLE GROUP’S BOARD OF DIRECTORS HAS RESOLVED ON A RIGHTS ISSUE OF APPROX SEK 40 MILLION AND AGREED A REVISED FINANCING PACKAGE 4,26 SEK | -43,20% | 0,54 MSEK

2026-02-28 18:40:00 Magle Chemoswed Holding AB enters into exclusive license agreement for amniotic stem cell technology

2026-02-18 18:00:00 Magle Group Issues Profit Warning Ahead of Q4 and Full-Year 2025 Results 8,10 SEK | -23,58% | 0,21 MSEK

2026-01-29 11:18:00 Magle Group Announces Strategic Refocus to Strengthen Profitability and Operational Discipline 10,50 SEK | -4,55% | 0,30 MSEK

2026-01-21 13:52:00 Magle Group Announces Planned Transition in Chief Operating Officer Role 14,60 SEK | -11,52% | 0,12 MSEK

2026-01-02 13:03:00 Magle Group today announces a change in executive leadership 17,10 SEK | -2,84% | 0,03 MSEK

2025-12-16 13:33:00 Magle Chemoswed Holding AB announces change of Certified Adviser to Redeye 15,00 SEK | -5,06% | 0,20 MSEK

2025-12-01 15:00:00 Magle Group Enters Strategic Distribution Agreement with Rifa Pharma for SmartPAN® and SmartGEL® in India. 17,70 SEK | -0,56% | 0,08 MSEK

2025-11-27 08:30:00 Magle Chemoswed Holding Announces Chairman Transition 17,60 SEK | -0,56% | 0,04 MSEK

2025-11-17 14:53:00 Magle Group Completes European Medical Device Filing for the Use of EmboCept® S in Genicular Artery Embolisation 19,10 SEK | +0,53% | 0,10 MSEK

2025-11-14 08:30:00 Magle Chemoswed Holding Reports Financial Results For Third Quarter 2025 19,00 SEK | -8,65% | 0,15 MSEK

2025-10-31 08:30:00 Magle Group Announces Revised Publication Date for Q3 2025 Due to Ongoing Consolidation Processes 19,00 SEK | -6,86% | 0,08 MSEK

2025-10-23 15:25:00 Magle Group sponsors inaugural VENTI Conference in Tokyo, Japan — supporting innovation in vascular embolotherapy and pain interventions 19,50 SEK | +2,63% | 0,00 MSEK

2025-10-22 08:56:00 Magle Biopolymers receives 2026 order showing a material increase in demand for one of its proprietary dextran derivatives 19,00 SEK | -7,77% | 0,42 MSEK

2025-10-20 10:40:00 Magle Group announces positive clinical evidence review of EmboCept® S for Genicular Artery Embolisation (GAE); regulatory filing in Europe now in preparation 20,60 SEK | +4,04% | 0,05 MSEK

2025-10-02 07:45:00 Magle Group Secures Registration of SmartPAN® in Singapore, Enabling Launch in Pancreatic Surgery 19,20 SEK | 0,00% | 0,01 MSEK

2025-08-01 07:30:00 Magle Chemoswed Holding Reports Financial Results For Second Quarter 2025 20,60 SEK | -2,83% | 0,21 MSEK

2025-07-29 09:00:00 Magle Group’s financial results for the second quarter anticipated to fall short of market expectations. 23,20 SEK | -12,12% | 0,30 MSEK

2025-06-24 17:20:00 Magle Group successfully places senior secured bonds of SEK 350 million 26,80 SEK | -0,74% | 0,00 MSEK

2025-06-13 07:30:00 Magle Group contemplates issuance of senior secured bonds 26,80 SEK | +2,29% | 0,02 MSEK

2025-06-05 17:54:00 The acquisition of all shares in Saving Chlora AB has been completed

2025-05-26 15:00:00 Bulletin from Annual General Meeting in Magle Chemoswed Holding AB (publ) held on the 26th of May 2025 26,40 SEK | +1,54% | 0,03 MSEK

2025-05-26 15:00:00 Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 26 maj 5 26,40 SEK | +1,54% | 0,03 MSEK

2025-05-22 09:56:00 Magle Chemoswed Holding Reports Financial Results For First Quarter 2025 25,40 SEK | -3,05% | 0,20 MSEK

2025-05-05 17:30:00 Magle Chemoswed Holding AB (publ) Releases Annual Report for 2024. 25,60 SEK | -1,54% | 0,05 MSEK

2025-04-27 18:30:00 Malmö, Sweden – Magle Group announces a revised publication date for its 2024 Annual Report, and its Q1 2025 Interim Report. 29,00 SEK | +2,11% | 0,00 MSEK

2025-04-25 16:30:00 Correction: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 28,40 SEK | -1,39% | 0,01 MSEK

2025-04-25 09:00:00 Magle PharmaCept Partners with Pancreatic Cancer Europe PCE to Advance Innovation in Pancreatic Cancer Care 28,40 SEK | -1,39% | 0,01 MSEK

2025-04-24 11:15:00 Magle Group Announces Acquisition of Saving Chlora AB 28,80 SEK | +0,70% | 0,06 MSEK

2025-04-24 09:00:00 Kallelse till årsstämma i Magle Chemoswed Holding AB (publ) 28,80 SEK | +0,70% | 0,06 MSEK

2025-04-24 09:00:00 Notice of Annual General Meeting in Magle Chemoswed Holding AB (publ) 28,80 SEK | +0,70% | 0,06 MSEK

2025-03-27 08:30:00 Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 31,00 SEK | -5,49% | 0,08 MSEK

2025-03-19 08:15:00 Magle Group initiates Randomized Controlled Multicenter Trial with leading European university hospitals to explore SmartPAN® efficacy 31,00 SEK | 0,00% | 0,00 MSEK

2025-02-26 18:00:00 Ingela Fritzson resigns from the Board of Directors of Magle Group 31,00 SEK | -4,32% | 0,16 MSEK

2025-02-17 09:00:00 Magle Group is pleased to announce Magle PharmaCept’s participation in the DPC, German Pancreatic Club congress, set to take place February 27-March 1, 2025, in Heidelberg, Germany. 34,60 SEK | +1,76% | 0,08 MSEK

2025-02-14 08:05:00 Magle Group Announces Revised Publication Date for Q4 2024 and Full-Year 2024 Reports Due to Ongoing Consolidation Process 34,00 SEK | 0,00% | 0,02 MSEK

2025-01-09 21:45:00 Magle Group offentliggör tilldelning i den riktade emissionen 37,40 SEK | 0,00% | 0,01 MSEK

2025-01-09 21:45:00 Magle Group announces allocation in the directed share issue 37,40 SEK | 0,00% | 0,01 MSEK

2024-12-30 12:30:00 Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB 34,80 SEK | +4,82% | 0,19 MSEK

2024-12-30 12:30:00 Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB 34,80 SEK | +4,82% | 0,19 MSEK

2024-12-20 15:30:00 Magle Group raises approximately SEK 36.8 million in the rights issue 34,00 SEK | +2,41% | 0,18 MSEK

2024-12-20 15:30:00 Magle Group tillförs cirka 36,8 MSEK i företrädesemissionen 34,00 SEK | +2,41% | 0,18 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Magle Chemoswed

Prenumeration

Kalender

Beskrivning

Intresserad av bolagets nyckeltal?

Vem äger bolaget?

Magle Chemoswed

Prenumeration

Kalender

Beskrivning

Intresserad av bolagets nyckeltal?

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden